Lose 15–25% of your body weight with physician-guided GLP-1 medications like Semaglutide and Tirzepatide.
Trusted across Texas
GLP-1 treatments
Board-certified oversight
Complete your online intake form in minutes.
Meet your provider via secure telehealth.
Medication prescribed if clinically eligible.
Medication shipped directly to your door.
GLP-1 receptor agonist. Reduces appetite, improves blood sugar regulation, and supports sustained fat loss.
Dual GIP/GLP-1 agonist. Clinically proven to deliver superior weight loss outcomes vs. single-agonist therapies.
Patients typically lose 15–25% of their body weight within 6–12 months of consistent treatment.
"I lost 28 pounds in 4 months. The process was seamless and the provider was incredibly supportive."
"Finally a program that actually works. I've tried everything — this is different."
"The telehealth visits are so convenient. My medication arrives right to my door every month."
Join hundreds of patients achieving real, lasting results with physician-guided GLP-1 therapy.
A simple, medically supervised process — from first assessment to medication at your door.
Secure, HIPAA-compliant form covering medical history, medications, allergies, and weight loss goals. Takes ~10 minutes.
Schedule and attend a virtual consultation with your board-certified provider via our secure telehealth platform.
If clinically appropriate, your provider prescribes Semaglutide or Tirzepatide and sends the prescription to our partner pharmacy.
Your medication is dispensed and shipped directly to your door. Discreet packaging, fast delivery.
Regular provider check-ins to monitor progress, adjust dosing, and provide ongoing clinical support.
A GLP-1 receptor agonist that mimics the hormone GLP-1 to regulate appetite and blood sugar. FDA-approved for chronic weight management.
Slows gastric emptying, reduces appetite signals, and improves insulin sensitivity.
Average 15% body weight reduction over 68 weeks in clinical trials.
Nausea, vomiting, constipation, diarrhea (typically mild and transient).
BMI ≥ 27 with weight-related condition, or BMI ≥ 30. Provider assessment required.
A dual GIP/GLP-1 receptor agonist — the most advanced weight loss medication currently available. Delivers superior outcomes vs. single-agonist therapies.
Activates both GIP and GLP-1 receptors, producing additive effects on appetite suppression and metabolic regulation.
Up to 22.5% body weight reduction in SURMOUNT-1 clinical trial.
Similar GI profile to Semaglutide. Dose-dependent nausea most common.
Same BMI criteria as Semaglutide. Provider will determine best fit during consultation.
Yes. All medications require a provider consultation and prescription. Our telehealth providers will assess your eligibility.
Most patients notice appetite changes within 2–4 weeks. Significant weight loss typically begins by month 2–3.
Amali Wellness is a self-pay clinic. We do not bill insurance. Transparent pricing, no surprise fees.
No hidden fees. No insurance required. Your monthly membership covers everything you need for physician-supervised weight loss.
| Feature | Starter | Premium |
|---|---|---|
| Telehealth provider visit | Monthly | Monthly + as needed |
| Prescription management | ✓ | ✓ |
| Medication shipping | ✓ | ✓ |
| Dose titration support | — | ✓ |
| Nutrition guidance | — | ✓ |
| Priority messaging | — | ✓ |
| Progress dashboard | Basic | Full analytics |
Driver's license, passport, or state ID
Take a live photo to match your ID